Latest Blog Posts
Search
Sort Results
Filter by Programming
Filter by Specific Population
Filter by Topic
Filter by Infection
Filter by Resource Category
Search results
Current filters: HIV, Reproductive and maternal health, English, Women, Pregnancy
29 search results
- CATIE statement on the use of antiretroviral treatment (ART) to maintain an undetectable viral load as a highly effective strategy to prevent perinatal transmission of HIV
-
2020, CATIE
Research summary - Webpage - Growing Your Family
-
2020, CATIE
Brochure - Webpage - Decreasing the risk of neural tube defects with dolutegravir
-
From TreatmentUpdate 233
2019, CATIE
Research summary - Webpage - HIV in pregnancy: Identification of intrapartum and perinatal HIV exposures
-
2019, Canadian Pediatric Society
Webpage
More info - FDA warns that Prezcobix should not be used by HIV-positive pregnant women
-
From TreatmentUpdate 228
2018, CATIE
Research summary - Webpage - PrEP for understudied populations: Exploring questions about efficacy and safety
-
From Prevention in Focus - Fall 2018
2018, CATIE
Research summary - Webpage - Agencies issue caution about use of dolutegravir by pregnant HIV-positive women
-
2018, CATIE
Research summary - Webpage - The H.E.R. Pregnancy Program
-
2018, Streetworks
Case study - Webpage - Researchers study the impact of co-infection with hepatitis viruses on pregnant women with HIV
-
2018, CATIE
Research summary - Webpage - Having an HIV-Negative Baby
-
From The Power of Undetectable: What you need to know about HIV treatment as prevention
2019, CATIE
Client resources - Webpage
